Outlook Therapeutics, Inc. · NASDAQ:OTLK
Tang Capital Management LLC's stake in Outlook Therapeutics, Inc. fell to 3.40% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Tang Capital Management LLC's stake in Outlook Therapeutics, Inc. fell to 3.40%, 1,500,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 3.40%
- Shares
- 1,500,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 3.40% | 1,500,000 |
| KEVIN TANG | 3.40% | 1,500,000 |
| TANG CAPITAL PARTNERS, LP | 3.40% | 1,500,000 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0% | 0 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Outlook Therapeutics, Inc.
- Tang Capital Management LLC
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · May 15, 2025
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026